- Home
- REPL vs FMBH Comparison
REPL vs FMBH Comparison
Compare REPL & FMBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- FMBH
- Stock Information
- Founded
- REPL 2015
- FMBH 1865
- Country
- REPL United States
- FMBH United States
- Employees
- REPL N/A
- FMBH N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- FMBH Major Banks
- Sector
- REPL Health Care
- FMBH Finance
- Exchange
- REPL Nasdaq
- FMBH Nasdaq
- Market Cap
- REPL 897.3M
- FMBH 987.0M
- IPO Year
- REPL 2018
- FMBH N/A
- Fundamental
- Price
- REPL $12.49
- FMBH $37.90
- Analyst Decision
- REPL Strong Buy
- FMBH Buy
- Analyst Count
- REPL 6
- FMBH 5
- Target Price
- REPL $17.50
- FMBH $44.00
- AVG Volume (30 Days)
- REPL 1.3M
- FMBH 62.9K
- Earning Date
- REPL 02-06-2025
- FMBH 01-23-2025
- Dividend Yield
- REPL N/A
- FMBH 2.53%
- EPS Growth
- REPL N/A
- FMBH N/A
- EPS
- REPL N/A
- FMBH 3.24
- Revenue
- REPL N/A
- FMBH $316,387,000.00
- Revenue This Year
- REPL N/A
- FMBH N/A
- Revenue Next Year
- REPL $300.41
- FMBH $4.33
- P/E Ratio
- REPL N/A
- FMBH $11.68
- Revenue Growth
- REPL N/A
- FMBH 22.37
- 52 Week Low
- REPL $4.92
- FMBH $28.86
- 52 Week High
- REPL $17.00
- FMBH $43.86
- Technical
- Relative Strength Index (RSI)
- REPL 50.53
- FMBH 33.15
- Support Level
- REPL $11.19
- FMBH $40.77
- Resistance Level
- REPL $12.79
- FMBH $42.40
- Average True Range (ATR)
- REPL 0.70
- FMBH 1.17
- MACD
- REPL -0.14
- FMBH -0.55
- Stochastic Oscillator
- REPL 52.21
- FMBH 16.90
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. It also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.